Table 1 Clinical characteristics of... | American Society of Hematology

Table 1

Clinical characteristics of patients with AML

Patient no.	Sample source	Blasts, %	CD33, %	CD34, %	FAB
1	PB	93	87	0	M0/M1
2	BM	90	99	85	M4
3	BM	85	99	99	M1
4	BM	90	99	30	M4
5	PB	45	80	99	M0
6	BM	65	50	99	M0
7	BM	43	52	50	M4
8	BM	60	99	0	M5
9	PB	90	97	14	M4
10	BM	83	76	86	M2
11	BM	95	92	0	M5

Patient no.	Sample source	Blasts, %	CD33, %	CD34, %	FAB
1	PB	93	87	0	M0/M1
2	BM	90	99	85	M4
3	BM	85	99	99	M1
4	BM	90	99	30	M4
5	PB	45	80	99	M0
6	BM	65	50	99	M0
7	BM	43	52	50	M4
8	BM	60	99	0	M5
9	PB	90	97	14	M4
10	BM	83	76	86	M2
11	BM	95	92	0	M5

The CD33 and CD34 surface expression was studied by flow cytometry gating on the blast population. The AML classification was made according to the French- American-British classification (FAB).

View Large

This Feature Is Available To Subscribers Only